Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Clarke NW, Armstrong AJ, Thiery-Vuillemin A, Oya M, Shore N, Loredo E, Procopio G, de Menezes J, Girotto G, Arslan C, Mehra N, Parnis F, Brown E, Schlürmann F, Joung JY, Sugimoto M, Virizuela JA, Emmenegger U, Navratil J, Buchschacher GL, Poehlein C, Harrington EA, Desai C, Kang J, Saad F. Clarke NW, et al. Among authors: desai c. NEJM Evid. 2022 Sep;1(9):EVIDoa2200043. doi: 10.1056/EVIDoa2200043. Epub 2022 Jun 3. NEJM Evid. 2022. PMID: 38319800
Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound study.
Roubaud G, Özgüroğlu M, Penel N, Matsubara N, Mehra N, Kolinsky MP, Procopio G, Feyerabend S, Joung JY, Gravis G, Nishimura K, Gedye C, Padua C, Shore N, Thiery-Vuillemin A, Saad F, van Alphen R, Carducci MA, Desai C, Brickel N, Poehlein C, Del Rosario P, Fizazi K. Roubaud G, et al. Among authors: desai c. Eur J Cancer. 2022 Jul;170:73-84. doi: 10.1016/j.ejca.2022.04.016. Epub 2022 May 19. Eur J Cancer. 2022. PMID: 35598359 Free article. Clinical Trial.
Current Practices in Genetic Testing for Prostate Cancer: The Indian Scenario.
Bakshi G, Rajappa S, Joshi A, Desai C, Addla S, Baxi H, Talwar V, Mohapatra PN, Shingla S, Kulkarni U. Bakshi G, et al. Among authors: desai c. Indian J Public Health. 2024 Jul 1;68(3):396-400. doi: 10.4103/ijph.ijph_686_23. Epub 2024 Sep 24. Indian J Public Health. 2024. PMID: 39321228 Free article.
Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast Cancer.
Rüschoff J, Penner A, Ellis IO, Hammond MEH, Lebeau A, Osamura RY, Penault-Llorca F, Rojo F, Desai C, Moh A, Atkey N, Baenfer G, Scheel AH, D'Arrigo C, Schildhaus HU, Viale G; HER2-Low Study Group. Rüschoff J, et al. Among authors: desai c. Arch Pathol Lab Med. 2024 Aug 8. doi: 10.5858/arpa.2024-0052-OA. Online ahead of print. Arch Pathol Lab Med. 2024. PMID: 39111775 Free article.
Prevalence and types of cancer in older Indians: A multicentric observational study across 17 institutions in India.
Noronha V, Rao AR, Pillai A, Kumar A, Rajappa S, Kapoor A, Mishra BK, Gupta T, Desai C, Pavithran K, Goel A, Vora C, Mailankody S, Hingmire S, Saha R, Kumar A, Sahoo TP, Chandrasekharan A, Kothari R, Kumar L, Ramaswamy A, Banavali S, Prabhash K. Noronha V, et al. Among authors: desai c. Cancer Epidemiol. 2024 Oct;92:102628. doi: 10.1016/j.canep.2024.102628. Epub 2024 Aug 2. Cancer Epidemiol. 2024. PMID: 39094297
388 results